About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
Liquidia Corp (LQDA) Insider Trading
18 open-market trades reported since Aug 19, 2026: 0 purchases worth $0 and 18 sales worth $25.7M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Roger Jeffs | CEO | 0 | $0 | 1 | $933K |
| Michael Kaseta | CFO | 0 | $0 | 1 | $539K |
| Russell Schundler | General Counsel | 0 | $0 | 1 | $390K |
| Rajeev Saggar | Chief Medical Officer | 0 | $0 | 3 | $6.23M |
| Scott Moomaw | Chief Commercial Officer | 0 | $0 | 1 | $252K |
| Jason Adair | Chief Business Officer | 0 | $0 | 2 | $5.30M |
| Dana Boyle | CAO | 0 | $0 | 1 | $168K |
| Sarah Krepp | Chief Human Resource Officer | 0 | $0 | 2 | $168K |
| Sanjeev Khindri | Chief Development Officer | 0 | $0 | 1 | $31K |
| Stephen M. Bloch | Director | 0 | $0 | 1 | $6.39M |
| Raman Singh | Director | 0 | $0 | 2 | $1.18M |
| Katherine Rielly-Gauvin | Director | 0 | $0 | 2 | $4.09M |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 13 | Roger JeffsCEO | ▼ SELL10b5-1 | $933K | |
| Oct 13 | Michael KasetaCFO | ▼ SELL10b5-1 | $539K | |
| Oct 13 | Russell SchundlerGeneral Counsel | ▼ SELL10b5-1 | $390K | |
| Oct 13 | Rajeev SaggarChief Medical Officer | ▼ SELL10b5-1 | $263K | |
| Oct 13 | Scott MoomawChief Commercial Officer | ▼ SELL10b5-1 | $252K | |
| Oct 13 | Jason AdairChief Business Officer | ▼ SELL10b5-1 | $208K | |
| Oct 13 | Dana BoyleCAO | ▼ SELL10b5-1 | $168K | |
| Oct 13 | Sarah KreppChief Human Resource Officer | ▼ SELL10b5-1 | $149K | |
| Oct 13 | Sanjeev KhindriChief Development Officer | ▼ SELL10b5-1 | $31K | |
| Oct 7 | Stephen M. BlochDirector | ▼ SELL | $6.39M | |
| Sep 15 | Raman SinghDirector | ▼ SELL | $619K | |
| Sep 15 | Raman SinghDirector | ▼ SELL | $560K | |
| Sep 3 | Sarah KreppChief Human Resource Officer | ▼ SELL10b5-1 | $19K | |
| Aug 25 | Jason AdairChief Business Officer | ▼ SELL10b5-1 | $5.09M | |
| Aug 21 | Katherine Rielly-GauvinDirector | ▼ SELL10b5-1 | $2.76M | |
| Aug 21 | Katherine Rielly-GauvinDirector | ▼ SELL10b5-1 | $1.33M | |
| Aug 19 | Rajeev SaggarChief Medical Officer | ▼ SELL | $3.70M | |
| Aug 19 | Rajeev SaggarChief Medical Officer | ▼ SELL | $2.27M |